Stocks to Watch Today: Vodafone Idea, Lupin, L&T Tech, and Others

Date:


The market declined 2.5 per cent in the opening trade but the recovery in the initial hour, which was followed by rangebound trade, helped the benchmark indices settle with a 1.5 per cent loss in the previous session. Global markets were also under pressure after Federal Reserve Chair Jerome Powell in his speech at Jackson Hole reiterated that the rate hikes to bring inflation to 2 per cent target are going to continue at the cost of pain to consumers and businesses. The rising oil prices also weighed on sentiment.

The BSE Sensex tanked 861 points to 57,973, while the Nifty50 fell 246 points to 17,313.

Stocks to Watch

Ugro Capital

The company said the Board of Directors has made an allotment of 50,000 non-convertible debentures having a face value of Rs 10,000 each, through private placement. The tenure of instrument is 24 months from the date of allotment and the coupon rate is 10.35 per cent per annum.

EXECUTION

The company received board approval for the appointment of Venkatesh Viswanathan as a Group Chief Financial Officer and key managerial personnel. His appointment is effective from August 30, 2022, and the company also designated him as Chief Investor Relations Officer. However, Amit Kumar Gupta has stepped down as Chief Financial Officer.

L&T Technology Services

The engineering services company firm has bagged a multi-million-dollar deal from BMW Group for the European premier car maker’s hybrid vehicles. As part of the 5-year deal, it will provide high-end engineering services for the company’s suite of infotainment consoles targeted for its family of hybrid vehicles.

Vodafone Idea

The debt-ridden telecom operator’s 5G services launch will depend on several factors such as use cases, customer demand, competitive dynamics etc. Vi Managing Director and CEO Ravinder Takker said that the promoters of the company have invested Rs 4,940 crore and the company is in active discussion with investors for fund raise.

Lupin

The drug maker said it has received a tentative approval from the USFDA to market Dasatinib tablets, used to treat certain types of cancer, in America in strengths of 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg. The product is a generic version of Bristol-Myers Squibb Company’s Sprycel tablets.

BC Power Controls

The company has received board approval for the issuance of 1.1 crore equity shares, on a preferential basis, to the promoter group category at a price of Rs 5.65 per share. The total fundraising was Rs 6.21 crore.

Krishna Institute of Medical Sciences

The company has entered into a definitive agreement to acquire a majority stake (51 percent) in SPANV Medisearch Lifesciences, Nagpur. SPANV is running a multi-speciality hospital – Kingsway Hospitals, having over 300+ beds. Existing promoters and shareholders will continue to hold the balance 49 percent stake. Post-acquisition, the hospital will be renamed ‘KIMS Kingsway Hospitals’.

Orient Cement

Franklin Templeton Mutual Fund sold 1.52 lakh equity shares or 0.07 per cent stake in the cement company on August 26. With this, it reduced its stake in the said company to 3.12 per cent, down from 3.2 per cent earlier.

Star Housing Finance

The Coronation Castles Pvt Ltd has offloaded a 0.07 per cent stake in the company via open market transactions on August 26. With this, its stake reduced to 0.06 per cent, from 0.13 per cent earlier.

The views and investment tips by experts in this News18.com report are their own and not those of the website or its management. Users are advised to check with certified experts before taking any investment decisions.

Read all the Latest Business News and Breaking News here



Source link

Share post:

Subscribe

Popular

More like this
Related

Leading Asset Manager Fidelity Introduces $5 Million Ethereum Index Fund

Fidelity Investments doubled down on its cryptocurrency efforts...

NHL 2022-23 season betting preview: Will favorites continue historic pace?

Commercial Content, 21+ The 2021-22 NHL Season may have...

Analysis | Elon Musk’s Everything App ‘X’ Is a Bad Idea

Elon Musk likes to “go big or go home.” So it...